SGMO
Sangamo Therapeutics·NASDAQ
--
--(--)
--
--(--)
SGMO Filings
Filing Date
Form Description
Form Type
2026-02-04
Form 8-K - Current report
Key Events
2026-02-04 · Key Events
Form 8-K - Current report
2026-02-04
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-04 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-02-03
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-02-03 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
